The Giorgio Foundation is proud to join with Dr Sameer Agnihotri of the University of Pittsburgh to fund an exciting proof of principle project. While the Giorgio Foundation works to fund research into treatments and a cure for disfiguring dermal tumors, we are also interested in other new exciting areas of research.
Neurofibromatosis Type 1 is caused by a mutation in the NF1 or tumor suppressor gene. A loss of the NF1 protein promotes over active cell growth and causes tumors as well as other problems. Dr Agnihotri will test the concept of adding NF1 back into the gene using a method called transplicing.
As research into gene therapy advances, the Giorgio Foundation is proud to fund this proof of concept in the hopes that one day, instead of treating the symptoms, we can fix the NF1 gene.
Watch this space for updates on this project.